Anatomical features and clinical correlations in Caucasian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy. by Inciardi, R. et al.
1 Vol. 62 - No. 5  M I N E R V A  C A R D I O A N G I O L O G I C A    
 
 
A 
 
 
 
                                                                                                            ? 
 
MINERVA CARDIOANGIOL  2014;62 (5):369-378 
 
 
 
 
 
 
Anatomical features and clinical correlations 
in caucasian patients with definite arrhythmogenic 
right ventricular dysplasia/cardiomyopathy 
 
 
R. M. INCIARDI 1, E. MARESI 2, G. COPPOLA 1, A. ROTOLO 1, F. CLEMENZA 3 
U. GIORDANO 4, E. LOMBARDO 5, R. SCHICCHI 6, R. TORCIVIA 7, S. ARROTTI 1 
R. IACONA 1, A. A. MINACAPELLI 1, P. ASSENNATO 1, S. NOVO 1 
 
 
 
 
Aim.  Arrhythmogenic right  ventrticular dys- 
plasia/cardiomyopathy (ARVD/C) is an in- 
herited cardiomyopathy characterized by 
fibrofatty replacement and a high  risk of ven- 
tricular  arrhythmias (VA) and sudden cardiac 
death  (SCD). The  aim  of  the  present investi- 
gation is to examine the  pathological profile 
and the clinical correlations in a group  of 
ARVD/C patients. 
Methods. We conducted a multicenter study 
evaluating  47   patients  (31   men;  mean   age 
37±14 years)  with  definite ARVD/C. Diagno- 
sis  was  established  according to  the  actual 
clinicomorphologic criteria  at autopsy or 
clinically. We  divided  the   study   population 
in  2  different groups. First  group   included 
28  alive  patients and  the  second 19  patients 
dead  suddenly. 
Results. Age   at  presentation  was   different 
in  the  two  groups (P=0.0015). We observed 
an  important association  regarding the  risk 
of  sudden death  and  the  history of  physical 
exercise (P=0.0017). Moreover patients with 
negative outcome (i.e.,  SCD,  cardiac   trans- 
plantation, congestive  heart   failure)  had   a 
significantly association with  biventricular 
form  of  ARVD/C  (P=0.0034) and  age  pres- 
entation (P=0.003). Left  ventricular (LV) in- 
volvement  was   frequently  observed  in  the 
two  groups (17% and 32% respectively). Post- 
mortem examination revealed frequent in- 
flammatory infiltrates (26%) indicating active 
myocarditis, which probably justify  the  fatal 
arrhythmic events occurred in these patients. 
Conclusion.   Frequent  LV  involvement   jus- 
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tifies the  recent   adoption of  the  broad  term 
Arrhythmogenic  Cardiomyopathy. Early  age 
presentation, sport   activity   and   the   biven- 
tricular  form of ARVD/C represent important 
predictors of adverse outcome that can be 
useful to early  identify patients at high  risk. 
Key  words: Cardiomyopathies - Death,  sudden  - 
Young adult - Exercise. 
 
 
rrhythmogenic  right   ventrticular   dys- 
plasia/cardiomyopathy   (ARVD/C),   is 
a rare inherited cardiomyopathy, with an 
estimated  prevalence in the  general  popu- 
lation  of 1 per  5000.1  ARVD/C is typically 
transmitted  as an autosomal  dominant  trait 
with  variable  penetrance  and  the  patho- 
logic  hallmark  is a  progressive  right  ven- 
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tricular  (RV) myocyte loss with fibrofatty 
replacement, especially regarding the  apex, 
inflow  and  outflow  tracts  (so-called ―trian- 
gle  of dysplasia‖).2, 3  Postmortem examina- 
tion  of patients with  ARVD/C often  shows 
RV myocardial atrophy with  wall  thinning, 
aneurysms, and  global  dilation   of  the  RV. 
However left ventricular is so frequently in- 
volved,  justifying the  adoption of the  broad 
term    ―arrhythmogenic   cardiomyopathy‖.4 
Many studies  showed that genetic  mutation 
alterating  desmosomal   and   non    desmo- 
somal proteins underlie the histopatho- 
logical  changes leading   to  the  progressive 
myocardiocite  loss.5,   6   Histological  altera- 
tions   interfere  with   the   normal   conduc- 
tion  of  electrical  impulses, thus  leading  to 
electrical  instability  and  frequently to  ven- 
tricular  arrhythmias (VA), which  worsen pa- 
tients’ prognosis by increasing their  risk of 
a sudden cardiac  death (SCD) especially in 
young   people and  athletes. Sports  activity 
has been shown to increase the risk of sud- 
den death in people with ARVC by five-fold, 
since  acute  volume overload and  stretching 
of the right ventricle  during  effort as well as 
sympathetic  stimulation are  major  triggers 
of life-threatening arrhythmias. Diagnosis is 
established according to the  Task Force  di- 
agnostic  criteria  revised  on  2010.7  The  aim 
of this  multicenter study  is to  examine the 
clinicopathologic profile  of ARVD/C in a 
group of  affected  patients. For  this  reason 
we analyzed two group of patients with dif- 
ferent  clinical onset  presentation. In the first 
group diagnosis was  established in vivo, in 
the second  at autopsy  in patients  died sud- 
denly for lethal VA. 
 
 
Materials  and methods 
 
Study population 
The   study   population   consists   of   2 
groups.   First  group   included   28  patients 
(18 male; mean  age  42±14 years), and  the 
second  group  19 patients  (13 male;  mean 
age  29±10  years).  Patients  were  enrolled 
at  6  collaborative   medical  centers.  Upon 
their  clinical onset  presentation they  were 
divided   in  two   different   groups.  In  both 
cases  diagnosis was  established according 
to  the  specific  clinocopathologic protocols 
developed  by  the  revised   Task  Force  cri- 
teria.7   Definite   diagnosis  of  ARVD/C  was 
based on  the  presence of either  2 major  or 
1 major and  2 minor.  Diagnosis was consid- 
ered  borderline when 1 major  and  1 minor 
or 3 minor  criteria  from different  categories 
were  fulfilled. To enhance the diagnostic 
specificity  no  patient with  only  minor  cri- 
teria  and  borderline diagnosis entered the 
study.  Patients  whose diagnosis was  based 
on   the   original   1994  diagnostic  criteria,8 
were  reviewed upon the  latest  to  confirm 
or exclude the  diagnosis. 
 
First group 
All medical  records of each  patients were 
carefully  reviewed for  information regard- 
ing  demographics, detailed family  history, 
presenting symptoms, electrocardiographic 
abnormalities on a 12-lead electrocardio- 
gram,  24-h  Holter   monitoring, clinical  ar- 
rhythmic  events  (syncope, ventricular fi- 
brillation   [VF], ventricular tachycardia). 
Echocardiographic and  magnetic resonance 
(MR) imaging  were  obtained for  a  correct 
evaluation  of  the   structural  abnormalities 
and  the  extent  of right  ventricular dysfunc- 
tion.  Right  ventricular angiography  and/or 
endomyocardial biopsy  were  performed 
under discretion of the  managing cardiolo- 
gists, such  us programmed ventricular stim- 
ulation. Patients’  management therapy was 
established   according   to  the  clinical  fea- 
tures  and  risk stratification  of each  patient 
considering drug therapy, ICD implantation, 
catheter  ablation  and  cardiac  transplanta- 
tion. Follow-up  data  were  available  for all 
28 study patient. Patients were followed  up 
at each collaborative medical center at bian- 
nual and yearly intervals. Data included  in- 
vasive and non invasive investigation, clini- 
cal arrhythmic events, quality of life and 
device interrogation. 
All patients   provided   written   informed 
consent  before  joining  the  study.  The  au- 
thors  of this manuscript  have  certified that 
all  experiments  were  performed   in  strict 
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compliance with  the  2008  Helsinki  Decla- 
ration  amendment on ethics  requirements. 
 
Second group 
Analysis  of macroscopic and  histopatho- 
logic   abnormalities   of   ARVD/C   derived 
from  a  systematic  study  performed by  the 
―Department of  Legal  Medicine‖  of  the  ―P. 
Giaccone Hospital‖,  on entirely  hearts  of 
patients died  suddenly at  postmortem ex- 
amination. Sudden death was defined as an 
unexpected natural  phenomenon in which 
loss  of  all  vital  functions occurred  instan- 
taneously  or within 1 hour  of the onset  of 
symptoms. Macroscopic examination in- 
cluded measurement of  heart   weight   and 
wall  thickness. The  following regions  were 
systematically examined:  apex,  inflow  and 
outflow  tracts  of RV, posterolateral and  an- 
terolateral walls  of  both  ventricles and  in- 
terventricular septum. The  morphologic 
changes that  we  addressed were  wall  thin- 
ning,  cavity  enlargement or aneurysm, my- 
ocardial   atrophy and  fatty  or  fibrofatty  re- 
placement. RV involvement was considered 
widespread or regional upon the pathologic 
extension of the  disease. Histologic  exami- 
nation  was  performed from  each  region  of 
the right and  left ventricles and  the septum. 
All myocardial section  were  formalin-fixed 
and paraffin-embedded and stained with 
hematoxylin-eosin   or   with   Mallory-Azan 
stain.   The   following  morphologic  lesions 
were  assessed in the  histologic specimens: 
myocardial atrophy, fatty or fibrofatty  re- 
placement,  myocite degeneration (necrosis, 
apoptosis,  myocytolysis) and interstitial cell 
infiltrates. No ECG or cardiac imaging data 
were available for this patients. 
Statistical analysis 
Results are expressed as mean±SD.  Com- 
parisons between groups of  patients were 
made  using  Student  t-test  or one-way 
ANOVA. Categorial   variables   are  reported 
as  frequency (percentage)  and   compared 
between groups by  the  chi-square or  Fish 
exact  test.  A P value  <0.05 was  considered 
significant. 
 
 
Results 
 
Demographic findings 
The  first group included 28 patients (18 
male; 64.3%) with an age at time of diagno- 
sis ranged from  17 to  68 years  (mean age 
42±14  years).  The  second group included 
19 patients (13 male;  68.4%) and  the  age  at 
time  of  death ranged from  16 to  43 years 
(mean age  29±10  years).  Baseline   clinical 
characteristics are summarized in Table  I. 
 
Imaging findings of the living group 
All 28  patients of  the  living  group  un- 
derwent ultrasound (US) examination for a 
correct   evaluation of  the  structural abnor- 
malities  and  the  extent  of right  ventricular 
dysfunction. Wall  motion  abnormalities  of 
the  RV (akinesis/dyskinesis) was  observed 
in 26 patients (93%) especially in the  apex, 
inflow  and  outflow  tracts  (RVOT). Twenty- 
two patients (79%) showed an hypertrophic 
RV trabeculation   with  diastolic  bulging  of 
the free wall in 8 patients  (29%). RVOT val- 
ues   were   frequently   increased   (35.6±6.6 
mm in parasternal  long-axis view, PLAX). 
 
 
Table  I.— Baseline clinical characteristics of the study population. 
 
Clinical characteristics Living patients Sudden  death P value 
Age at presentation (mean±SD) 42±14 29±10 0.0015 
Male (N.; %) 18 (64.2%) 13 (68.4%) 0.98 
Symptomatic at presentation/before death  (N.; %) 27 (97%) 1 (5%) 0.00001 
Biventricular  involvement (N.;%) 5 (17%) 6 (32%) 0.45 
History of sport  activity (N.; %) 5 (17%) 14 (74%) 0.0004 
Family History of sudden death  (N.; %) 8 (28%) 0 (0%) 0.03 
Family History of ARVD/C (N.;%) 3 (11%) 0 (0%) 0.38 
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MR was  performed in 25 patients (89%), 
and  in  all  patients there  was  at  least  1 or 
more  abnormal MR sign. The most  frequent 
abnormalities were focal right ventricular 
diskinesia (21  patients; 84%),  fatty  infiltra- 
tion (23 patients; 92%), right ventricular 
aneurysm (10 patients; 40%). Abnormal en- 
hancement in  the  RV wall  on  the  delayed 
enhancement images   was  observed in  16 
patients  (84%).  In  5  patients  (17%)  was 
found  a biventricular involvement with  fo- 
cal left ventricular diskinesia and  fatty infil- 
tration. 
 
Clinical outcome of the living group 
In the  first group 8 patients (28%) had  a 
family history of sudden death  and 3 patients 
(11%) of ARVD/C. In almost all cases we ob- 
served  a symptomatic presentation not  cor- 
related with precipitating factors. Only 2 pa- 
tients  (7%) referred physical  exercise before 
symptoms onset  and  3 patients (10%) were 
competitive athletes. Finally  only  1 patient 
(3%) was asymptomatic. Symptoms more 
frequently referred were palpitation and 
syncope (13  patients in  both   cases;  46%), 
presyncope (8 patients; 28%), cardiac  arrest 
(5 patients; 18%), dizziness (4 patients; 14%), 
chest  pain  (3 patients; 10%), dyspnea (2 pa- 
tients;  7%), signs  and  symptoms of RV fail- 
ure (1 patients; 3%). We studied our patients 
over  a mean  follow-up of 6.0±4.4 years.  To 
this  date  no  mortality  was  reported. At the 
time  of  the  diagnosis  more   than   half  pa- 
tients (15 patients, 54%) received an ICD 
implantation based to the  estimated risk of 
SCD according with  the  last  guidelines for 
management of patients with  ventricular ar- 
rhythmias.9  ICD implantation was  associat- 
ed with antiarrhythmic agents  in 13 patients 
(87%). Radiofrequency catheter ablation for 
the treatment of ventricular arrhythmias was 
performed in  6 patients (21%).  During  the 
follow-up, 8 patients (61%) received an ICD 
implantation because of  the  relapse of  ar- 
rhythmic   events   although they  were  using 
antiarrhythmic drugs  or underwent catheter 
ablation for VT. Of the  23 patients who  re- 
ceived  an  ICD, 20 (86%)  had  received ap- 
propriate ICD therapy (Figure  1). An appro- 
priate  ICD shock  intervention for ventricular 
fibrillation  (VF)/ventricular flutter (VFL) was 
seen  in 12 patients (52%). Two patients (7%) 
underwent cardiac  transplantation as a final 
therapeutic option due  to refractory  conges- 
tive  heart  failure  and  1  patients (3%)  was 
placed on a waiting  list. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.—Kaplan-Meier analysis of appropriate ICD interventions. 
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Clinical outcome of the sudden death group 
In  the  second group no  patients had  a 
family history  of sudden death or ARVD/C. 
Sudden cardiac  death represented the  first 
clinical  presentation of  ARVD/C in  18  pa- 
tients (95%), only 1 patient (5%) had  an his- 
tory  of  premature  ventricular contractions 
(PVC). In whole patients death occurred 
immediately (within  1h from symptoms on- 
set):  in  14 patients (74%)  occurred during 
physical  exercise and in 5 patients (26%) 
occurred at rest. Eleven patients (58%) were 
competitive athletes. 
 
Results correlations 
Comparing the  two  groups results  an im- 
portant difference in terms  of age presenta- 
tion.  Indeed there   is  a  statistically   signifi- 
cant  difference between  the  mean  ages  at 
presentation (42±14  years  vs. 29±10  years; 
P=0.0015). We observed moreover how  the 
event   of  death  occurred as  frequently  as 
early is the  onset  of the  disease (Figure  2). 
No   significant    differences  existed    be- 
tween  the   risk  of  sudden  death  and   the 
male sex. We observed moreover an impor- 
tant difference regarding the risk of sudden 
death and  the  history  of  physical   exercise 
(78.5%  vs.  24%;  P=0.001),   suggesting the 
improved risk  of  SCD deriving   from  sport 
activity. We finally analyzed patients with 
negative outcome (SCD, cardiac  transplan- 
tation,  congestive heart  failure).  We  found 
a significantly  association with biventricular 
form of ARVD/C and  age  presentation. The 
risk  of  adverse outcome is  more  frequent 
in patients with a biventricular involvement 
of the  disease (46% vs. 4%; P=0.0034)  and 
in  patients with  an  early  age  presentation 
(P=0.003; Figure  3). 
 
Pathological findings 
 
Gross morphologic features 
 
Analysis of pathologic abnormalities of 
ARVD/C was performed on 19 hearts  at 
necropsy study  (Table  II). 
Hearts showed a mean weight  of 370±66.5 
g  (range from  270  to  470  g).  On  external 
examination right  side  appeared yellowish 
with grayish  nuances. In 5 cases (26%) were 
identified aneurismal dilatation of  RV wall 
at one  or  more  of the  following locations: 
RV outlet  in 3 cases (16%), RV inlet in 1 case 
(5%) and  apex  in 1 case  (5%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.—Boxplots of age at presentation in the sudden  death group  and living population. (The central box repre- 
sents the values from the lower to upper  quartile (25 to 75 percentile).  The middle line represents  the median.  The 
vertical line extends  from the minimum to the maximum value). 
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Pathologic  findings Mean or % 8 cases (42%). Global  mild-severe RV dilata- 
Heart weight 
RV aneurysm 
370±66.5 g 
26 
tion was seen  in 6 cases  (31.5%) and  in the 
other  cases  RV dimensions were  normal  (13 
–  Outflow  tract 16 cases;  68.5%).  RV free  wall  thickness was 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.—Boxplots of age  at presentation in the  group with  and  without adverse outcome. (The  central  box  repre- 
sents  the  values  from  the  lower  to upper quartile (25 to 75 percentile). The  middle line  represents the  median. The 
vertical  line extends from  the  minimum to the  maximum value). 
 
 
Table   II.— Pathological findings of 19 heart 
analyzed. 
 
(58%; more  frequently in the  outflow  tract 
and  apex)  and  widespread in the remaining 
 
 
 
 
–  Inflow tract 
–  Apex 
RV involvement 
–  Diffuse 
–  Regional 
5                                   increased in 5 cases  (26%) and  disclosed a 
5                                   
variable  degree of  thinning in  the  remain- 
58                                 ing  14  cases  (74%),  with  areas  so  thin  as 
42                                 to  appear completely devoid of  muscle  at 
LV involvement                                           32 
IVS involvement                                         11 
transillumination  (Figure   4B).  LV  involve- 
ment  was  diagnosed at  gross  examination 
RV thickness 
–  Reduced 
–  Increased 
RV atrophy 
–  Fibrofatty 
–  Fatty 
Interface  between survival and  degen- 
erative  myocardium 
–  Infiltrative pattern 
–  Cardiomyopathic pattern 
2.88±1.45 mm 
74 
26 
 
42 
58 
 
 
26 
74
in  6  hearts   (32%),  with  aneurismal  dilata- 
tion regarding LV free wall. In 2 cases (11%) 
we found an involvement  of interventricular 
septum  (IVS). 
 
 
Histologic findings 
 
Histologic  examination   revealed   severe 
Myocardial  inflammation                           26 
 
 
 
All hearts  showed  severe  and transmural 
RV muscle loss, with varying degrees  of ex- 
tent and distribution, associated with fatty or 
fibrofatty replacement (Figure 4A). Atrophy 
of RV musculature  was regional in 11 cases 
and  transmural  loss  of RV myocardium  in 
all hearts specimens  with residual myocytes 
<  60% by  morphometric  analysis  (Figure 
4C, D). According  to gross  inspection,  mi- 
croscopic lesions  diffusely  affected  the  RV 
free wall from the subepicardial to the sub- 
endocardial  layer, with fatty (11 cases; 58%) 
or  fibrofatty  (8  cases;  42%) replacement. 
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Figure  4.—Gross specimens of the  examined heart  at necropsy. (A) Note  the  massive RV with  extensive fat that  re- 
place  entire  RV epicardium, and  a thin  free  wall  as to appear completely devoid of muscle at transillumination (B). 
Histopathologic (hematoxylin-eosin; x250)  images  show  a transmural fatty  (C) and  fibrofatty  (D)  replacement with 
scatterd survival  myocardium. 
 
Surviving myocaridum with degenerative 
changes and atrophy was observed in a thin 
subendocardial  layer,   the   trabeculae and 
scattered in areas  with fatty or fibrofatty  re- 
placement. Myocytes  showed degenerative 
changes, myocytolysis, necrosis and  apop- 
tosis (Figure 5A). Multifocal inflammatory 
infiltrates  (active  myocarditis) were  seen  in 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                               
Figure 5.—Histopathologic  images show  several apoptotic  bodies containing  uniformly dense  masses of chromatin, 
indicating apoptotic  process  (A), and multifocal inflammatory infiltrates (active myocarditis) (B) (hematoxylin-eosin; 
x250). 
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5 cases  (26%). Infiltrates  consisted of scat- 
tered  interstitial  collections of mononuclear 
cells close  to necrotic or degenerative myo- 
cytes (Figure  5B). 
The damage of conduction tissue was ob- 
served  in the two cases with interventricular 
septum  involvement, showing  a  fibrofatty 
replacement of hissian  bifurcation. Analysis 
of  the  areas  dividing  survival  myocardium 
from  degenerative tissue,  showed 2 differ- 
ent  morphologic patterns: infiltrative  (with 
irregular  and  blending interface) in 5 cases 
(26%),  and  cardiomyopathic (with  a linear 
and regular  interface) in 14 cases (74%). 
Infiltrative   pattern  presented  the   follow- 
ing  features:   increased RV free  wall,  fatty 
replacement, RV involvement only, absence 
of inflammatory infiltrates.  Cardiomyopath- 
ic pattern showed a thin  RV free wall (with 
aneurismal dilatation in 4 cases;  21%), fatty 
or fibrofatty  replacement (32% and  42% re- 
spectively), inflammatory infiltrates  and  LV 
involvement. 
Finally  two  patients of  the  living  group 
underwent  endomyocardial biopsy   of  the 
septum and  the  free  wall  of  the  RV for  a 
better   diagnostic approach  of  the  disease. 
Both  of  them  revealed myocyte loss  (with 
residual myocytes < 60%), fibrofatty  re- 
placement and in one  case inflammatory in- 
filtrates. These  data confirmed the diagnosis 
of ARVD/C.\1\2 
 
 
Discussion 
 
Our   study   analyzed  the   main   clinical 
and  anatomical  features  of ARVD/C, a rare 
cardiomyopathy frequent  cause  of sudden 
death  especially  in young  and athletes.10,  11 
Baseline clinical characteristics of our study 
population are  similar to  data  reported  in 
literature,12,   13   with  a  prevalence  in  male 
sex and an age presentation during the sec- 
ond to fifth decade  of life. We observed  an 
important  rate of death  related  to ARVD/C 
and interestingly no patients  of the sudden 
death group had a family history of the dis- 
ease,  justifying the  difficulty to achieve  an 
early diagnosis in asymptomatic patients 
before  death.  Our  data  shows  an  associa- 
tion  between death and  the  age  presenta- 
tion of the disease. It can be explained with 
a  strict  genetic   basis  characterizing young 
patients that  usually  onset  with  life-threat- 
ening   arrhythmias.  Many  studies   showed 
as  juvenile   form  of  ARVD/C  presents an 
adverse  outcome,14   and   the   only   way  to 
avoid   lethal   events   is  represented by  ge- 
netic   screening,  to  identify   patients  with 
high  risk,  and  exercise  restriction.  Clinical 
and  genetic   studies   revealed that  physical 
exercise increase the  risk  of sudden death 
in  people  with  ARVD/C  by  five-fold  15,16. 
Even our study confirmed an association 
between sport  activity and risk of death. 
Excessive  mechanical stress,  such  as during 
competitive sport  activity  and  training,  can 
aggravate the  underlying dysplastic lesions 
and  accelerate disease progression. For this 
reason we consider reasonable the exercise 
restriction recommended  by  clinicians   for 
therapeutic management in patients with 
ARVD/C.17 According to this a lifesaving 
strategy is the detection of symptom-free 
individuals at preparticipation screening for 
sport  eligibility. 
Instead of high mortality  rate in our pop- 
ulation, we observed a survival rate of 100% 
during  follow-up in patients with  a correct 
and  early  diagnosis of  ARVD/C. Only  few 
cases  presented  arrhythmic relapses or  re- 
fractory  heart  failure  thus  requiring cardiac 
transplantation. Many studies  tried  to iden- 
tify long-term prognostic predictors of  ad- 
verse  outcome in this patients.18, 19  We con- 
sidered  patients with  adverse  outcome  in 
term of sudden  death,  refractory heart  fail- 
ure  and  heart  transplantation. Our  results 
revealed  that biventricular  involvement  and 
early age  presentation of the  disease  have 
an incremental  power  in predicting  adverse 
outcome. Biventricular involvement under- 
lies an important  widespread and  progres- 
sion  of ARVD/C thus  alterating  ventricular 
function.  As previously  reported   even  an 
early age presentation shows  an important 
risk not only in term of death but of adverse 
outcome. Pathologic findings revealed dif- 
ferent  anatomic  features  of  ARVD/C with 
special references to LV involvement, in- 
flammatory  infiltrates  and  apoptotic   proc- 
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ess.  Many authors agree  with  the  adoption 
of the  broad term  ―arrhythmogenic cardio- 
myopathy‖ 3  due  to  the  description of  the 
frequent  involvement of  LV  ventricle   and 
left-dominant form of ARVD/C.4  In our 
experience  LV  involvement  was  observed 
in  32% of  cases  in  the  second group, and 
in  17% of  cases  in  the  first group. As de- 
scribed  in previous studies,20  we  observed 
3 main  form  of ARVD/C: classic  with  main 
RV involvement,  left  dominant with  main 
LV  involvement and  biventricular  with  an 
involvement  of  both   ventricles.  Our  find- 
ings  showed other  two  important features 
of ARVD/C: inflammatory infiltrates  and 
apoptotic process. Although it is not  clear 
whether  inflammation in  ARVC is  a  pri- 
mary event  or a reaction to spontaneous 
necrosis, inflammatory infiltrates  are an 
histopathologic marker  of an ongoing myo- 
cardial  damage that  suggests a progressing 
myocardial  disease.21   Moreover   apoptosis 
has  recently  been shown to  be  a mode of 
myocyte death in ARVC and  might  provide 
a unifying  explanation for progressive myo- 
cardial loss.22  These  changes are frequent in 
ARVD/C and  probably play  a major  part  in 
triggering life-threatening  arrhythmias.  We 
finally  report the  recognition in 2 cases  of 
fatty replacement regarding hissian  bifurca- 
tion as possible agents  able  to trigger  lethal 
arrhythmias. There  are  some  limitations  to 
consider when interpreting the result of this 
study.  A prospective, randomized study  de- 
sign  is difficult  to perform in patients with 
ARVD/C because of the  relatively  low  dis- 
ease prevalence.  The study design was that 
of an  observational survey  of 6 collabora- 
tive medical  centers,  with  potential  limita- 
tions in patients selection. Although written 
informed consent was acquired prospec- 
tively,  all  clinical  and   demographic  data 
were  collected  retrospectively.   This  might 
be a source  for recall bias. Moreover, since 
the study was not prospectively  performed, 
results from the direct comparison  between 
data  of living and  autopsy  subjects  should 
be   interpreted  with  caution.   Finally  our 
study is based on a small sample size. How- 
ever, this is a rare disease and our inclusion 
criteria were very strictly, including only pa- 
tients  with  definite  diagnosis of ARVD/C in 
order  to  enhance the  specificity  of our  re- 
sults. Our  purpose is to extent  in the  future 
our  study  population in  order  to  collect  a 
complete registry  of entire  Sicily. 
 
 
Conclusions 
 
Arrhythmogenic Right Ventrticular Dys- 
plasia/Cardiomyopathy is an  unusual con- 
dition   with   a   variable    clinical   presenta- 
tion.  Our  study  confirms  a previous report 
by  Corrado et al.,23  which  identify  3 main 
clinical   form   of  ARVD/C:  a  silent   phase 
with  concealed  abnormalities and  sudden 
death might  be  the  first  manifestation, an 
overt  right  ventricular electrical  phase and 
an  end-stage with  right  ventricular or  biv- 
entricular  failure.   Actually   the   spectrum 
of  our  study  population ranges   from  con- 
cealed RV changes detected at  autopsy in 
previously asymptomatic young  patients to 
biventricular cardiomyopathy with severe 
pump failure.  Moreover  we  find that biven- 
tricular  involvement, early  age  at presenta- 
tion,  physical  exercise represent predictors 
that play  an important role in terms  of pro- 
gression and  adverse outcome of ARVD/C. 
However to this day is often  difficult preco- 
ciously  identify  silent  form  of ARVD/C that 
frequently lead  to  life-threatening arrhyth- 
mias. 
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